State Of Wyoming Apellis Pharmaceuticals, Inc. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$35.07 - $59.21 $5,260 - $8,881	150 New	150 $7,000
Q4 2021 Feb 11, 2022	SELL	$30.74 - $49.16 $8,484 - $13,568	-276 Closed	0 $0
Q3 2021 Feb 11, 2022	SELL	$31.4 - $69.84 $14,726 - $32,754	-469 Reduced 62.95%	276 $9,000
Q2 2021 Feb 11, 2022	BUY	$40.9 - $64.9 $28,998 - $46,014	709 Added 1969.44%	745 $47,000
Q1 2021 Feb 08, 2022	BUY	$40.8 - $57.39 $1,468 - $2,066	36 New	36 $2,000

302

112M

3.85M

1.09M

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.19B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.